On 2017 May 26, Hilda Bastian commented:

These are interesting results, showing the critical importance of transparency about trials of pharmaceuticals. However, it does not identify the trials it found, or identify the phases of those trials. It would be helpful if the authors were to release these data, for those interested in the results of this study, anyone interested in doing similar work, and those looking for trials on these particular drugs.

The abstract reports the number of participants in the unpublished trials. It would be good to also provide the number of participants in the published trials.

Note: I wrote a blog post about this study and its context.

On 2017 May 26, Hilda Bastian commented:

These are interesting results, showing the critical importance of transparency about trials of pharmaceuticals. However, it does not identify the trials it found, or identify the phases of those trials. It would be helpful if the authors were to release these data, for those interested in the results of this study, anyone interested in doing similar work, and those looking for trials on these particular drugs.

The abstract reports the number of participants in the unpublished trials. It would be good to also provide the number of participants in the published trials.

Note: I wrote a blog post about this study and its context.